| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |